Epilepsy Clinical Trial
— MEG-SEEGOfficial title:
Definition of Links Between Non-invasives Methods and Intracerebral EEG With Simultaneous Recordings.
Verified date | April 2019 |
Source | Assistance Publique Hopitaux De Marseille |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Presurgical evaluation of epileptic patients require a precise mapping of cerebral regions
implied in epileptic discharges and in normal function.
The current practice in most cases is to implant intracerebral electrodes in order to
localize these regions in a reliable manner. However, non-invasive methods have been
developed in order to record brain activity with no risk for the patient.
Still, it is necessary to validate and improve the signal processing methods and the
underlying models these methods in order to optimize their use in clinical practice. To do
so, it is necessary to record simultaneously electroencephalogram (EEG) and
magnetoencephalogram (MEG) and stereo encephalogram SEEG (intracerebral). Such simultaneous
recordings will permit to confront the exact same activity recorded non-invasively at the
surface of the head, and represented on the brain thanks to the model and directly within the
brain.
The objective is to define the conditions under which one can represent faithfully the
activity measured intracerebrally from the surface measurements.
It will be record simultaneously MEG, scalp EEG and intracerebral EEG on a series of 60
patients. It will be record resting state signals, as well as stimulation protocols. The
interictal epileptic discharges will be marked on the different modalities, and evoked
potentials/fields computed in response to protocols. Sensitivity of recordings to activity
visible on depth recordings will be evaluated as a function of localization of brain
generators. Advanced signal processing methods will be used such as source localization and
independent component analysis, in order to increase sensitivity of measures.
Status | Completed |
Enrollment | 60 |
Est. completion date | April 2019 |
Est. primary completion date | April 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Patients for whom implanting intracerebral electrodes is underway Exclusion Criteria: - Patients minors - Pregnant or lactating women |
Country | Name | City | State |
---|---|---|---|
France | Assistance Publique Hôpitaux de Marseille | Marseille |
Lead Sponsor | Collaborator |
---|---|
Assistance Publique Hopitaux De Marseille |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The number of epileptic discharges | Measurement of epileptic activity by electroencephalogram | 60 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04595513 -
Stopping TSC Onset and Progression 2: Epilepsy Prevention in TSC Infants
|
Phase 1/Phase 2 | |
Completed |
NCT02909387 -
Adapting Project UPLIFT for Blacks in Georgia
|
N/A | |
Completed |
NCT05552924 -
Self Acupressure on Fatigue and Sleep Quality in Epilepsy Patients
|
N/A | |
Terminated |
NCT01668654 -
Long-term, Open-label Safety Extension Study of Retigabine/Ezogabine in Pediatric Subjects (>= 12 Years Old) With POS or LGS
|
Phase 3 | |
Not yet recruiting |
NCT05068323 -
Impact of Interictal Epileptiform Activity on Some Cognitive Domains in Newly Diagnosed Epileptic Patients
|
N/A | |
Completed |
NCT03994718 -
Creative Arts II Study
|
N/A | |
Recruiting |
NCT04076449 -
Quantitative Susceptibility Biomarker and Brain Structural Property for Cerebral Cavernous Malformation Related Epilepsy
|
||
Completed |
NCT00782249 -
Trial Comparing Different Stimulation Paradigms in Patients Treated With Vagus Nerve Stimulation for Refractory Epilepsy
|
N/A | |
Completed |
NCT03683381 -
App-based Intervention for Treating Insomnia Among Patients With Epilepsy
|
N/A | |
Recruiting |
NCT05101161 -
Neurofeedback Using Implanted Deep Brain Stimulation Electrodes
|
N/A | |
Active, not recruiting |
NCT06034353 -
Impact of Pharmacist-led Cognitive Behavioral Intervention on Adherence and Quality of Life of Epileptic Patients
|
N/A | |
Recruiting |
NCT05769933 -
Bridging Gaps in the Neuroimaging Puzzle: New Ways to Image Brain Anatomy and Function in Health and Disease Using Electroencephalography and 7 Tesla Magnetic Resonance Imaging
|
||
Not yet recruiting |
NCT06408428 -
Glioma Intraoperative MicroElectroCorticoGraphy
|
N/A | |
Not yet recruiting |
NCT05559060 -
Comorbidities of Epilepsy(Cognitive and Psychiatric Dysfunction)
|
||
Completed |
NCT02952456 -
Phenomenological Approach of Epilepsy in Patients With Epilepsy
|
||
Completed |
NCT02977208 -
Impact of Polymorphisms of OCT2 and OCTN1 on the Kinetic Disposition of Gabapentin in Patients Undergoing Chronic Use
|
Phase 4 | |
Completed |
NCT02646631 -
Behavioral and Educational Tools to Improve Epilepsy Care
|
N/A | |
Recruiting |
NCT02539134 -
TAK-935 Multiple Rising Dose Study in Healthy Participants
|
Phase 1 | |
Terminated |
NCT02757547 -
Transcranial Magnetic Stimulation for Epilepsy
|
N/A | |
Completed |
NCT02491073 -
Study to Evaluate Serum Free Thyroxine (FT4) and Free Triiodothyronine (FT3) Measurements for Subjects Treated With Eslicarbazeine Acetate (ESL)
|
N/A |